Tomasello Luisa, Distefano Rosario, Nigita Giovanni, Croce Carlo M
Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, United States.
Front Cell Dev Biol. 2021 Jun 9;9:668648. doi: 10.3389/fcell.2021.668648. eCollection 2021.
MicroRNAs (miRNAs or miRs) are the most characterized class of non-coding RNAs and are engaged in many cellular processes, including cell differentiation, development, and homeostasis. MicroRNA dysregulation was observed in several diseases, cancer included. Epitranscriptomics is a branch of epigenomics that embraces all RNA modifications occurring after DNA transcription and RNA synthesis and involving coding and non-coding RNAs. The development of new high-throughput technologies, especially deep RNA sequencing, has facilitated the discovery of miRNA isoforms (named isomiRs) resulting from RNA modifications mediated by enzymes, such as deaminases and exonucleases, and differing from the canonical ones in length, sequence, or both. In this review, we summarize the distinct classes of isomiRs, their regulation and biogenesis, and the active role of these newly discovered molecules in cancer and other diseases.
微小RNA(miRNA或miR)是最具特征的一类非编码RNA,参与许多细胞过程,包括细胞分化、发育和内环境稳定。在包括癌症在内的多种疾病中都观察到了微小RNA失调。表观转录组学是表观基因组学的一个分支,涵盖DNA转录和RNA合成后发生的所有RNA修饰,涉及编码和非编码RNA。新的高通量技术的发展,尤其是深度RNA测序,促进了由脱氨酶和外切核酸酶等酶介导的RNA修饰产生的miRNA异构体(称为异源miR)的发现,这些异构体在长度、序列或两者上都与经典异构体不同。在这篇综述中,我们总结了不同类别的异源miR、它们的调控和生物发生,以及这些新发现的分子在癌症和其他疾病中的积极作用。